199 related articles for article (PubMed ID: 34033837)
1. Progresses in polymeric nanoparticles for delivery of tyrosine kinase inhibitors.
Foroughi-Nia B; Barar J; Memar MY; Aghanejad A; Davaran S
Life Sci; 2021 Aug; 278():119642. PubMed ID: 34033837
[TBL] [Abstract][Full Text] [Related]
2. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
3. Polymeric nanoparticles: the future of nanomedicine.
Banik BL; Fattahi P; Brown JL
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2016; 8(2):271-99. PubMed ID: 26314803
[TBL] [Abstract][Full Text] [Related]
4. Nanoparticles and cancer therapy: Perspectives for application of nanoparticles in the treatment of cancers.
Aghebati-Maleki A; Dolati S; Ahmadi M; Baghbanzhadeh A; Asadi M; Fotouhi A; Yousefi M; Aghebati-Maleki L
J Cell Physiol; 2020 Mar; 235(3):1962-1972. PubMed ID: 31441032
[TBL] [Abstract][Full Text] [Related]
5. Nanoformulations of small molecule protein tyrosine kinases inhibitors potentiate targeted cancer therapy.
Yin Y; Yuan X; Gao H; Yang Q
Int J Pharm; 2020 Jan; 573():118785. PubMed ID: 31678384
[TBL] [Abstract][Full Text] [Related]
6. Using Peptide Aptamer Targeted Polymers as a Model Nanomedicine for Investigating Drug Distribution in Cancer Nanotheranostics.
Zhao Y; Houston ZH; Simpson JD; Chen L; Fletcher NL; Fuchs AV; Blakey I; Thurecht KJ
Mol Pharm; 2017 Oct; 14(10):3539-3549. PubMed ID: 28880092
[TBL] [Abstract][Full Text] [Related]
7. Novel Approaches for Efficient Delivery of Tyrosine Kinase Inhibitors.
Moradpour Z; Barghi L
J Pharm Pharm Sci; 2019; 22(1):37-48. PubMed ID: 30636671
[TBL] [Abstract][Full Text] [Related]
8. Nanotechnology of Tyrosine Kinase Inhibitors in Cancer Therapy: A Perspective.
Russo E; Spallarossa A; Tasso B; Villa C; Brullo C
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34207175
[TBL] [Abstract][Full Text] [Related]
9. Drug targeting systems for cancer therapy: nanotechnological approach.
Tigli Aydin RS
Mini Rev Med Chem; 2015; 14(13):1048-54. PubMed ID: 25138089
[TBL] [Abstract][Full Text] [Related]
10. Recent Advances in pH-Sensitive Polymeric Nanoparticles for Smart Drug Delivery in Cancer Therapy.
Lim EK; Chung BH; Chung SJ
Curr Drug Targets; 2018 Feb; 19(4):300-317. PubMed ID: 27262486
[TBL] [Abstract][Full Text] [Related]
11. The Clinical Translation of Organic Nanomaterials for Cancer Therapy: A Focus on Polymeric Nanoparticles, Micelles, Liposomes and Exosomes.
Palazzolo S; Bayda S; Hadla M; Caligiuri I; Corona G; Toffoli G; Rizzolio F
Curr Med Chem; 2018; 25(34):4224-4268. PubMed ID: 28875844
[TBL] [Abstract][Full Text] [Related]
12. Immune Cell-Mediated Biodegradable Theranostic Nanoparticles for Melanoma Targeting and Drug Delivery.
Xie Z; Su Y; Kim GB; Selvi E; Ma C; Aragon-Sanabria V; Hsieh JT; Dong C; Yang J
Small; 2017 Mar; 13(10):. PubMed ID: 28026115
[TBL] [Abstract][Full Text] [Related]
13. Tiny technology proves big: a challenge at engineering, medicine and pharmaceutical sciences interface.
Mahapatra AK; Murthy PN; Samoju S; Mohapatra AK
Crit Rev Ther Drug Carrier Syst; 2014; 31(1):1-47. PubMed ID: 24579766
[TBL] [Abstract][Full Text] [Related]
14. Nanomedicine of tyrosine kinase inhibitors.
Smidova V; Michalek P; Goliasova Z; Eckschlager T; Hodek P; Adam V; Heger Z
Theranostics; 2021; 11(4):1546-1567. PubMed ID: 33408767
[TBL] [Abstract][Full Text] [Related]
15. Recent Developments in the Application of Polymeric Nanoparticles as Drug Carriers.
Moritz M; Geszke-Moritz M
Adv Clin Exp Med; 2015; 24(5):749-58. PubMed ID: 26768624
[TBL] [Abstract][Full Text] [Related]
16. Polymeric nanoparticles for cancer therapy.
Parveen S; Sahoo SK
J Drug Target; 2008 Feb; 16(2):108-23. PubMed ID: 18274932
[TBL] [Abstract][Full Text] [Related]
17. Tumor-targeted and multi-stimuli responsive drug delivery system for near-infrared light induced chemo-phototherapy and photoacoustic tomography.
Feng Q; Zhang Y; Zhang W; Shan X; Yuan Y; Zhang H; Hou L; Zhang Z
Acta Biomater; 2016 Jul; 38():129-42. PubMed ID: 27090593
[TBL] [Abstract][Full Text] [Related]
18. Nanosized Modification Strategies for Improving the Antitumor Efficacy of MEK Inhibitors.
Li Y; Dong Q; Mei T; Zheng M; Kumar RR; Yu B; Wu C; Zhang H; An F
Curr Drug Targets; 2020; 21(3):228-251. PubMed ID: 31389313
[TBL] [Abstract][Full Text] [Related]
19. Recent advances in theranostic polymeric nanoparticles for cancer treatment: A review.
Indoria S; Singh V; Hsieh MF
Int J Pharm; 2020 May; 582():119314. PubMed ID: 32283197
[TBL] [Abstract][Full Text] [Related]
20. Nanomedicine for drug delivery and imaging: a promising avenue for cancer therapy and diagnosis using targeted functional nanoparticles.
Liu Y; Miyoshi H; Nakamura M
Int J Cancer; 2007 Jun; 120(12):2527-37. PubMed ID: 17390371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
